TrialPLoS medicine2020

Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.

Edward C Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.